Loading patent…
AssigneeCalmark Sweden AB
InventorsMathias Karlsson, Sofia Hiort af Ornäs
Estimating the term…
The present invention relates to a testing system for analyzing a risk of developing organ failure or presence of organ failure, said system comprising a disposable testing device arranged to receive a biological sample, which testing system is further arranged with means for measuring within said sample the total amount of at least a first biological marker in the form of an intracellular enzyme, and comprising means for analyzing the measured value of said intracellular enzyme, and based on the results thereof being arranged to communicate the risk of developing organ failure or presence of organ failure to an operator of said testing system. The present invention also relates to a method for analyzing a risk of developing organ failure, or analyzing presence of organ failure.
1-26. (canceled)
Testing system for analyzing a risk of developing organ failure or presence of organ failure, said system comprising a disposable testing device (6) arranged to receive a biological sample, wherein said testing system is configured with means (81, 61 A, 6 IB, 61C) for measuring within said sample the total amount of at least a first and a second biological marker, wherein the first biological marker is in the form of an intracellular enzyme and the second biological marker is in the form of albumin, and wherein the testing system further comprises means (83, 61A, 61B, 61C) for analyzing the measured value of said first and second biological markers, and based on the results thereof being configured to communicate the risk of developing organ failure or presence of organ failure to an operator of said testing system.
An in-vitro method for analyzing a risk of developing organ failure or presence of organ failure, said method comprising the steps of:
Dependencies are inferred from the claim text.